CVS Health (CVS)

• Market cap: $80.8B
• 1 day: 1.67%
• 5 days: 5.75%
• 1 month: 11.50%
• 3 months: 2.60%
• 6 months: 36.64%
• Year to date: 52.56%
• 1 year: 10.54%
• 5 years: 6.54%
• 10 years: -34.24%
• Sector: Healthcare
• Industry: Healthcare Plans

About: CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.

Employees: 300,000

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

177% more funds holding in top 10

Funds holding in top 10: 13 [Q4 2024] → 36 (+23) [Q1 2025]

64% more first-time investments, than exits

New positions opened: 273 | Existing positions closed: 166

53% more capital invested

Capital invested by funds: $47.2B [Q4 2024] → $71.9B (+$24.8B) [Q1 2025]

5% more funds holding

Funds holding: 1,636 [Q4 2024] → 1,714 (+78) [Q1 2025]

1.15% more ownership

Funds ownership: 83.08% [Q4 2024] → 84.23% (+1.15%) [Q1 2025]

7% more call options, than puts

Call options by funds: $2.18B | Put options by funds: $2.05B

29% less repeat investments, than reductions

Existing positions increased: 524 | Existing positions reduced: 743

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $71 5% upside
• Avg. target: $78 15% upside
• High target: $84 25% upside

8 analyst ratings

• positive: 6 75%
• neutral: 2 25%
• negative: 0 0%

Barclays Andrew Mok	17% upside $79	Overweight Maintained	2 Jun 2025
Truist Securities David Macdonald	25% upside $84	Buy Maintained	12 May 2025
Wells Fargo Stephen Baxter	25% upside $84	Overweight Maintained	6 May 2025
RBC Capital Ben Hendrix	20% upside $81	Outperform Maintained	5 May 2025
UBS Kevin Caliendo	5% upside $71	Neutral Maintained	2 May 2025